Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are ...

Eli Lilly (NYSE: LLY) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

Conservative commentator Megyn Kelly was seated near the front of a U.S. Senate hearing room Tuesday as former Fox News host Pete Hegseth was grilled by lawmakers. Kelly was seen in the second row of ...

A person who died in a Newport, Washington, house fire last week was identified as 82-year-old James P. Morrison, according to the Spokane County Medical Examiner's Office. The cause and manner of ...

A longtime pharmaceutical executive laments the woeful state of the industry and calls for new leadership to win back public ...

The risk of developing dementia may be much higher than previously thought, a study published Monday in the journal Nature Medicine has found.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

In this edition of InnovationRx, medical debts will be erased from credit histories, this farm is doubling down on raw milk ...